Drug Trial Radar · NCT05362292
TReating Incontinence for Underlying Mental and Physical Health
Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
Oct 4, 2022
Primary completion
May 2, 2027
Study completion Aug 2, 2027
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- May 5, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
Conditions
- Urinary Incontinence, Urge
- Urinary Incontinence
- Overactive Bladder
- Incontinence, Urge
- Incontinence, Urinary
- Incontinence
Interventions
Tolterodine Tartrate ERDrug
Anticholinergic
MirabegronDrug
Beta-3-adrenergic agonist
PlaceboDrug
matching placebo pill
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in composite cognitive function over 6 months (24 weeks) of treatment, using a composite cognitive score that incorporates normalized data from all domain-specific cognitive tests.Time frame: Baseline to 6 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California · Recruiting
University of California San Francisco
San Francisco, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.